SCHEMBL3089517

SCHEMBL3089517

Cn1cnc2c(N)nc(C3CCCC3)nc21

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 2/20 0.54
▸ ADORA1 P30542 3/20 0.46
▸ ADORA2A P29274 3/20 0.46
▸ PDE8B O95263 6/20 0.44
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ PI4KA P42356 3/20 0.40
▸ PI4K2B Q8TCG2 3/20 0.40
▸ PI4K2A Q9BTU6 3/20 0.40
▸ PI4KB Q9UBF8 3/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ PDE8A O60658 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6270232 0.98 CDK1 (0.53) CDK1ADORA1ADORA2APDE8BCYP1A2
SCHEMBL7738505 0.81 CDK1 (0.60) CDK1ADORA1ADORA2APDE8BPI4KA
SCHEMBL7438827 0.76 PI4KA (0.52) ADORA2APDE8BPKMPI4KAPI4K2B
SCHEMBL232039 0.75 ADORA2A (0.55) CDK1ADORA1ADORA2APDE8BCYP1A2
SCHEMBL6270235 0.75 CDK1 (0.47) CDK1ADORA1ADORA2A
SCHEMBL9233825 0.75 CDK1 (0.47) CDK1ADORA1ADORA2A
SCHEMBL15354448 0.75 CDK2 (0.63) CDK1ADORA1ADORA2APDE8BPI4KA
SCHEMBL15354446 0.75 CDK1 (0.63) CDK1ADORA1ADORA2APDE8BPI4KA
SCHEMBL28126184 0.75 PDE8B (0.35) PDE8B
SCHEMBL9482601 0.74 PDE8B (0.45) PDE8B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0383759-B1 N6 SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS DISCOVERY THERAPEUTICS INC (US) 1998-09-09 — — EP claimed
EP-0457773-A1 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, Inc. (US) 1991-11-27 — — EP claimed
WO-1990009178-A1 N6-SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, INC. (US) 1990-08-23 — — WO claimed
US-7795427-B2 Methods for inhibiting osteoclast differentiation, formation, or function and for increasing bone mass NEW YORK UNIVERSITY (US) 2010-09-14 — — US disclosed
US-20070191279-A1 Methods and compositions for treating disorders associated with increased bone turnover and osteopenia CRONSTEIN BRUCE N 2007-08-16 — — US disclosed
EP-0778836-B1 SUBSTITUTED 9-ALKYLADENINES ADERIS PHARMACEUTICALS INC (US) 2005-12-28 — — EP disclosed
EP-1602657-A2 Substituted 9-alkyladenines Discovery Therapeutics, Inc. (US) 2005-12-07 — — EP disclosed
EP-0880353-A4 COMPOSITIONS AND METHODS FOR MODULATING MELANIN PRODUCTION THERASYS INC (US) 2001-04-18 — — EP disclosed
WO-1999031101-A1 ADENOSINE RECEPTOR ANTAGONISTS WITH IMPROVED BIOACTIVITY UNIVERSITY OF SOUTH FLORIDA (US) 1999-06-24 — — WO disclosed
EP-0880353-A1 COMPOSITIONS AND METHODS FOR MODULATING MELANIN PRODUCTION Therasys, Inc. (US) 1998-12-02 — — EP disclosed
EP-0383759-B1 N6 SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS DISCOVERY THERAPEUTICS INC (US) 1998-09-09 — — EP disclosed
EP-0778836-A4 SUBSTITUTED 9-ALKYLADENINES DISCOVERY THERAPEUTICS INC (US) 1998-02-04 — — EP disclosed
EP-0778836-A1 SUBSTITUTED 9-ALKYLADENINES Discovery Therapeutics, Inc. (US) 1997-06-18 — — EP disclosed
WO-1996006845-A1 SUBSTITUTED 9-ALKYLADENINES DISCOVERY THERAPEUTICS, INC. (US) 1996-03-07 — — WO disclosed
EP-0383759-A4 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS — 1993-03-17 — — EP disclosed
EP-0457773-A4 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS — 1993-03-10 — — EP disclosed
EP-0457773-A1 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, Inc. (US) 1991-11-27 — — EP disclosed
EP-0383759-A1 N6 SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS Whitby Research Incorporated (US) 1990-08-29 — — EP disclosed
WO-1990009178-A1 N6-SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, INC. (US) 1990-08-23 — — WO disclosed
WO-1988008303-A1 N6-SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS NELSON RESEARCH AND DEVELOPMENT COMPANY (US) 1988-11-03 — — WO disclosed
Send feedback